Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Eli Lilly and Company albashi ta raba

Rahoton kuɗi na kamfanin Eli Lilly and Company, ya bayar da rahoto game da ribar da aka samu na LLY a shekarar 2024. Yaushe Eli Lilly and Company ya buga rahotanni na kudi kan riba da asarar?
Ƙara zuwa widget din
Ƙara zuwa widget din

Yaushe Eli Lilly and Company ya wallafa wata sanarwa da asara?

Rahotanni na Eli Lilly and Company da kuma asarar da aka wallafa sau ɗaya a cikin kwata, an wallafa asusun ajiyar kuɗi na Eli Lilly and Company a ranar 31/03/2021.

Mene ne riba daga hannun jari na Eli Lilly and Company?

Abinda aka kiyasta ta hannun Eli Lilly and Company ya kasance 1.87 $ a cikin rahoton kudi na ƙarshe.

Yaushe Eli Lilly and Company zai buga bayanan asara da asarar gaba?

Rahoton na gaba akan asusun riba da asarar Eli Lilly and Company zai kasance ranar Yuni 2024.

Eli Lilly and Company albashi a rabon - halayen kuɗi na kamfanin akan girman darajar sa. Ana tara albashi da kaso gwargwadon tsari: adadin ribar da kamfanin ya samu na lokacin hada-hadar gwargwadon rahoton aikin hukuma an rarrabe shi da adadin hannun jari a kamfanin. A bayyane yake cewa Eli Lilly and Company Albashin kowace riba halayen kuɗi ne na wani lokaci. Riba na Eli Lilly and Company - jimlar riba na lokacin hada-hadar kudi.

Nuna:
To

Riba Eli Lilly and Company

Duk ribar Eli Lilly and Company riba ce. Hakan bai da mahimmanci ga masu hannun jari masu zaman kansu. Mafi nuna alama mai ban sha'awa ita ce riba ta kowace kashi, wanda kai tsaye ke rinjayar adadin rabon kowane rabo. Ranan rahoton ribar Eli Lilly and Company ya danganta da dokar ƙasar ta rijistar kamfanin. Duk kwanakin Eli Lilly and Company an nuna rahoton ribar a cikin jadawalinmu da kuma teburinmu.

Bincike na hamsin Eli Lilly and Company

Abubuwan da suka samu ta hanyar Eli Lilly and Company an kirga su daidai da tsarin da aka samu: kudin shiga da ya raba hannun jarin duk hannun jari a kamfanin. Ana samun albashi ta kashin Eli Lilly and Company ana la'akari da shi na wani lokacin kudi sannan kuma ana bayar da rahoton rahoton kuɗi akan ribar kamfanin gaba ɗaya. Eli Lilly and Company ana samun albashi ta kowane rashi don lokacin rahoton da ya gabata a teburinmu (saman layi) ko jadawali (shafi mafi kyau). Eli Lilly and Company Albashin da ya samu na kwata-kwata don nazarin lissafin kudi shine babban rahoto na wucin gadi na shekarar kudi.

LLY rahoton kwanan wata Raba ta kashi
Ana kiyasta yawan kuɗin da aka raba ta hanyar rarraba kudaden shiga (ko riba) ta yawan adadin kamfanonin kamfanin.
Canja don shekara %
31/03/2021 1.87 USD -
31/12/2020 2.75 USD +58.96% ↑
30/09/2020 1.54 USD +4.05% ↑
30/06/2020 1.89 USD +26% ↑
31/12/2019 1.73 USD +13.48% ↑
30/09/2019 1.48 USD +3.7% ↑
30/06/2019 1.5 USD +11.91% ↑
31/03/2019 1.33 USD +15.64% ↑
31/12/2018 1.33 USD +24.72% ↑
30/09/2018 1.39 USD +31.39% ↑
30/06/2018 1.5 USD +23.05% ↑
31/03/2018 1.34 USD +17.63% ↑
31/12/2017 1.14 USD +9.78% ↑
30/09/2017 1.05 USD +7.28% ↑
30/06/2017 1.11 USD +22.76% ↑
31/03/2017 0.98 USD +13.63% ↑
31/12/2016 0.95 USD +25.47% ↑
30/09/2016 0.88 USD +26.16% ↑
30/06/2016 0.86 USD +16.27% ↑
31/03/2016 0.83 USD +10.59% ↑
31/12/2015 0.78 USD +6.11% ↑
30/09/2015 0.89 USD +13.47% ↑
30/06/2015 0.9 USD +13.12% ↑
31/03/2015 0.87 USD +8.77% ↑
31/12/2014 0.75 USD -0.861% ↓
30/09/2014 0.66 USD -54.994% ↓
30/06/2014 0.68 USD -53.999% ↓
31/03/2014 0.7 USD -49.207% ↓
31/12/2013 0.74 USD -5.837% ↓
30/09/2013 1.11 USD +25.04% ↑
30/06/2013 1.16 USD +30.14% ↑
31/03/2013 1.14 USD +34.46% ↑
31/12/2012 0.85 USD -2.967% ↓
30/09/2012 0.79 USD -35.953% ↓
30/06/2012 0.83 USD -53.353% ↓
31/03/2012 0.92 USD -49.355% ↓
31/12/2011 0.87 USD -35.834% ↓
30/09/2011 1.13 USD -2.136% ↓
30/06/2011 1.18 USD +7.29% ↑
31/03/2011 1.24 USD +5.82% ↑
31/12/2010 1.11 USD +19.39% ↑
30/09/2010 1.21 USD +13.18% ↑
30/06/2010 1.24 USD +7.89% ↑
31/03/2010 37.76 USD +11.17% ↑
31/12/2009 0.91 USD -13.957% ↓
30/09/2009 1.2 USD -0.473% ↓
30/06/2009 1.12 USD +2.76% ↑
31/03/2009 1.2 USD +3.62% ↑
31/12/2008 1.07 USD +17.35% ↑
30/09/2008 1.04 USD +16.98% ↑
30/06/2008 0.99 USD +20.64% ↑
31/03/2008 0.92 USD +21.67% ↑
31/12/2007 0.9 USD +9.24% ↑
30/09/2007 0.91 USD +10.62% ↑
30/06/2007 0.9 USD +9.52% ↑
31/03/2007 0.84 USD +5.11% ↑
31/12/2006 0.85 USD +4.67% ↑
30/09/2006 0.8 USD +11.33% ↑
30/06/2006 0.76 USD +13.24% ↑
31/03/2006 0.77 USD +13.71% ↑
31/12/2005 0.8 USD +6.18% ↑
30/09/2005 0.73 USD +4.42% ↑
30/06/2005 0.67 USD -1.863% ↓
31/03/2005 0.68 USD -0.27% ↓
31/12/2004 0.75 USD +9.63% ↑
30/09/2004 0.69 USD +2.63% ↑
30/06/2004 0.68 USD +12.09% ↑
31/03/2004 0.7 USD +14.75% ↑
31/12/2003 0.67 USD -1.865% ↓
30/09/2003 0.66 USD -3.322% ↓
30/06/2003 0.64 USD -1.461% ↓
31/03/2003 0.61 USD -0.0452% ↓
31/12/2002 0.68 USD -
30/09/2002 0.68 USD -
30/06/2002 0.61 USD -
31/03/2002 0.58 USD -

Eli Lilly and Company Albashin da ya samu na kwata-kwata a kowane bangare shima yana daya daga cikin alamun ƙungiyar ta samu riba, dukda cewa ƙarancin shahararrun albashin da ake samu kowace shekara. Profitarshen kwata-kwata Eli Lilly and Company a yau shine alƙawarin da aka ayyana na hukuma akan ƙarshen kwata na ƙarshe. Canza riba Eli Lilly and Company domin shekara ta kasance darajar ma'anar da ke nuna canjin ribar idan aka kwatanta da irin wannan lokacin a bara. Canjin Eli Lilly and Company ribar kwata-kwata don shekara ba ta da mahimmanci kamar sauyi a Eli Lilly and Company ribar shekara idan aka kwatanta da na bara.

An nuna canjin riba a matsayin kashi. Tarihin ribar Eli Lilly and Company na shekarun da suka gabata da lokacin bayar da rahoto yana cikin teburin “ribar kwata-kwata”. Eli Lilly and Company Tarihin samun kuɗaɗen shiga ana samun su akan layi sama da shekaru 10 da suka gabata. The Eli Lilly and Company cibiyar tattara ribar kamfanin na shekarun da suka gabata ana samun su daga hanyoyin buɗe.

Kudin hannun jari Eli Lilly and Company

Finance Eli Lilly and Company